Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 22, 2002
Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits?
P Murali Doraiswamy, K Ranga Rama Krishnan, Ravi Anand, et al.
Case Reports in Rheumatology
|
May 11, 2013
Unilateral RS3PE in a Patient of Seronegative Rheumatoid Arthritis
Ankur Nandan Varshney, Nilesh Kumar, Ashutosh Tiwari, et al.
Biological Psychiatry
|
August 14, 2003
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial
Steven G Potkin, Larry Alphs, Chuanchieh Hsu, et al.
Transfusion Medicine Reviews
|
October 17, 2017
A Study of the Pharmacokinetic Properties and the In Vivo Kinetics of Erythrocytes Loaded With Dexamethasone Sodium Phosphate in Healthy Volunteers
Shodeinde A Coker, Zbigniew M Szczepiorkowski, Alan H Siegel, et al.
The American Journal of Psychiatry
|
February 2, 2002
A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography
Steven G Potkin, Gustavo Alva, Kirsten Fleming, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 22, 2014
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
Rupam Borgohain, Jozsef Szasz, Paolo Stanzione, et al.
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
Nature Communications
|
May 25, 2019
Evidence for fungi and gold redox interaction under Earth surface conditions
Tsing Bohu, Ravi Anand, Ryan Noble, et al.
Schizophrenia Bulletin
|
January 6, 2005
The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients
Larry Alphs, Ravi Anand, M Zahur Islam, et al.
Alzheimer Disease and Associated Disorders
|
June 19, 2002
Barriers to drug discovery and development for Alzheimer disease
Howard M Fillit, Alan W O'Connell, William M Brown, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 22, 2002
Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits?
P Murali Doraiswamy, K Ranga Rama Krishnan, Ravi Anand, et al.
Case Reports in Rheumatology
|
May 11, 2013
Unilateral RS3PE in a Patient of Seronegative Rheumatoid Arthritis
Ankur Nandan Varshney, Nilesh Kumar, Ashutosh Tiwari, et al.
Biological Psychiatry
|
August 14, 2003
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial
Steven G Potkin, Larry Alphs, Chuanchieh Hsu, et al.
Transfusion Medicine Reviews
|
October 17, 2017
A Study of the Pharmacokinetic Properties and the In Vivo Kinetics of Erythrocytes Loaded With Dexamethasone Sodium Phosphate in Healthy Volunteers
Shodeinde A Coker, Zbigniew M Szczepiorkowski, Alan H Siegel, et al.
The American Journal of Psychiatry
|
February 2, 2002
A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography
Steven G Potkin, Gustavo Alva, Kirsten Fleming, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 22, 2014
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
Rupam Borgohain, Jozsef Szasz, Paolo Stanzione, et al.
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
Nature Communications
|
May 25, 2019
Evidence for fungi and gold redox interaction under Earth surface conditions
Tsing Bohu, Ravi Anand, Ryan Noble, et al.
Schizophrenia Bulletin
|
January 6, 2005
The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients
Larry Alphs, Ravi Anand, M Zahur Islam, et al.
Alzheimer Disease and Associated Disorders
|
June 19, 2002
Barriers to drug discovery and development for Alzheimer disease
Howard M Fillit, Alan W O'Connell, William M Brown, et al.
Page
of 5